Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) HKSE

2.81

-0.01(-0.35%)

Updated at December 24 12:08PM

Currency In HKD

Valuation

Market Cap2.39B
Enterprise Value1.36B
P/E Ratio-138.44
PEG Ratio0.92
Price/Sales Ratio1.36
Price/Book Ratio3.84
Enterprise/Revenue-0.2
Enterprise/EBITDA3.68

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.09
Operating Margin-0.13

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.03

Income Statement

Revenue709.4M
Revenue/Share0.68
Gross Profit648.19M
EBITDA48.09M
Net Income39.73M
Diluted EPS0.04

Balance Sheet

Total Cash1.22B
Total Cash/Share1.08
Total Debt17.44M
Total Debt/Equity0.01
Current Ratio8.68
Book Value Per Share2.18

Price History

52-Week Change12.85
52-Week High5.29
52-Week Low2.13
Moving Average 50 Days3.1
Moving Average 200 Days3.22

Statistics

Average Volume1.95M
Shares Outstanding340M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.6
Payout Ratio-1.49
Last Split FactorN/A
Last Split DateN/A